These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 30290407)

  • 1. Approaches to dyslipidemia treatment in children and adolescents.
    Iughetti L; Predieri B; Bruzzi P; Balli F
    Expert Rev Endocrinol Metab; 2008 Sep; 3(5):615-633. PubMed ID: 30290407
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rational approach to the treatment for heterozygous familial hypercholesterolemia in childhood and adolescence: a review.
    Iughetti L; Predieri B; Balli F; Calandra S
    J Endocrinol Invest; 2007 Sep; 30(8):700-19. PubMed ID: 17923804
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of dyslipidemia in children and adolescents.
    Holmes KW; Kwiterovich PO
    Curr Cardiol Rep; 2005 Nov; 7(6):445-56. PubMed ID: 16256015
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Statins in the Management of Pediatric Dyslipidemia.
    Ross JL
    J Pediatr Nurs; 2016; 31(6):723-735. PubMed ID: 27496827
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical and laboratory assessment of cardiovascular risk in children: Guidelines for screening, evaluation, and treatment.
    Kwiterovich PO
    J Clin Lipidol; 2008 Aug; 2(4):248-66. PubMed ID: 21291741
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Consistency in efficacy and safety of ezetimibe coadministered with statins for treatment of hypercholesterolemia in women and men.
    Bennett S; Sager P; Lipka L; Melani L; Suresh R; Veltri E;
    J Womens Health (Larchmt); 2004 Dec; 13(10):1101-7. PubMed ID: 15650343
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dyslipidemia: management using optimal lipid-lowering therapy.
    Ito MK
    Ann Pharmacother; 2012 Oct; 46(10):1368-81. PubMed ID: 23032652
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of childhood hypercholesterolemia with HMG-CoA reductase inhibitors.
    Duplaga BA
    Ann Pharmacother; 1999 Nov; 33(11):1224-7. PubMed ID: 10573325
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atorvastatin in the treatment of primary hypercholesterolemia and mixed dyslipidemias.
    Yee HS; Fong NT
    Ann Pharmacother; 1998 Oct; 32(10):1030-43. PubMed ID: 9793596
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lipid-lowering medications for children and adolescents.
    Miller ML; Wright CC; Browne B
    J Clin Lipidol; 2015; 9(5 Suppl):S67-76. PubMed ID: 26343214
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacodynamics and pharmacokinetics of the HMG-CoA reductase inhibitors. Similarities and differences.
    Lennernäs H; Fager G
    Clin Pharmacokinet; 1997 May; 32(5):403-25. PubMed ID: 9160173
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of Hypercholesterolemia, Appropriateness of Therapeutic Approaches and New Drugs in Patients with High Cardiovascular Risk.
    Agabiti Rosei E; Salvetti M
    High Blood Press Cardiovasc Prev; 2016 Sep; 23(3):217-30. PubMed ID: 27567901
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination therapy in dyslipidemia: where are we now?
    Catapano AL; Farnier M; Foody JM; Toth PP; Tomassini JE; Brudi P; Tershakovec AM
    Atherosclerosis; 2014 Nov; 237(1):319-35. PubMed ID: 25299967
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical determinants and treatment gaps in familial hypercholesterolemia: Data from a multi-ethnic regional health service.
    Zafrir B; Jubran A; Lavie G; Halon DA; Flugelman MY; Shapira C
    Eur J Prev Cardiol; 2017 May; 24(8):867-875. PubMed ID: 28186442
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Screening and Management of Dyslipidemia in Children and Adolescents.
    Schefelker JM; Peterson AL
    J Clin Med; 2022 Oct; 11(21):. PubMed ID: 36362707
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Treatment with statins in children with familial hypercholesterolemia].
    Kamińska E; Hennig M; Brandt A; Bautembach Minkowska J; Myśliwiec M
    Dev Period Med; 2016; 20(4):328-334. PubMed ID: 28216488
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recognition and management of dyslipidemia in children and adolescents.
    Kwiterovich PO
    J Clin Endocrinol Metab; 2008 Nov; 93(11):4200-9. PubMed ID: 18697860
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.